scispace - formally typeset
D

David M. Hwang

Researcher at Sunnybrook Health Sciences Centre

Publications -  184
Citations -  9146

David M. Hwang is an academic researcher from Sunnybrook Health Sciences Centre. The author has contributed to research in topics: Lung transplantation & Lung. The author has an hindex of 48, co-authored 179 publications receiving 7241 citations. Previous affiliations of David M. Hwang include Toronto General Hospital & University Health Network.

Papers
More filters
Journal ArticleDOI

Disentangling Interactions in the Microbiome: A Network Perspective.

TL;DR: Network-based analytical approaches have the potential to help disentangle complex polymicrobial and microbe–host interactions, and thereby further the applicability of microbiome research to personalized medicine, public health, environmental and industrial applications, and agriculture.
Journal ArticleDOI

Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.

TL;DR: RAS is a novel form of CLAD that exhibits characteristics of peripheral lung fibrosis and significantly affects survival of lung transplant patients.
Journal ArticleDOI

Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies.

TL;DR: Tumor thickness appears to be a strong predictor for cervical lymph‐node involvement in squamous cell carcinoma of the oral cavity, but a precise clinically optimal TT cutoff point has not been established and a meta‐analysis is conducted.
Journal ArticleDOI

Lung microbiota across age and disease stage in cystic fibrosis.

TL;DR: Community diversity and lung function are greatest in patients less than 10 years of age and lower in older age groups, plateauing at approximately age 25, and lower community diversity correlates with worse lung function in a multivariate regression model.
Journal ArticleDOI

Pulmonary pathology of severe acute respiratory syndrome in Toronto.

TL;DR: It is indicated that the lungs of patients who die of SARS are almost always positive for the SARS-associated coronavirus by RT-PCR, and may show features of both diffuse alveolar damage and acute fibrinous and organizing pneumonia patterns of acute injury.